Research

Cellular

Semaglutide improves the function and inflammatory status of endothelial progenitor cells (EPCs) by inhibiting LPS-induced macrophage expression of miR-155 in exosomes.

Semaglutide may be beneficial in improving endothelial function in obesity-related inflammation.

StrongSupportsmedium confidence
Semaglutide improved the cell viability of EPCs and also inhibited the expression of inflammatory factors in EPCs as well as miR-155 in exosomes.
Xiaoyu Pan et al. · International Immunopharmacology · 2023

Why this rating

The study design involves direct experimental interventions and observations.

Source

Semaglutide alleviates inflammation-Induced endothelial progenitor cells injury by inhibiting MiR-155 expression in macrophage exosomes

Xiaoyu Pan et al. · International Immunopharmacology · 2023

DOI 10.1016/j.intimp.2023.110196

otherCited 27×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →